From the genes evaluated here, BRCA1, BRCA2, and PALB2 are part of the ACMG Secondary Findings v3.0 list [35] and laboratories are now recommended to report GPV in these genes even in individuals without a personal or family history of cancer when next generation sequencing is performed [36]. Here, BRCA1 is linked to cancer.